27 Jun 2024 · 1 min read
Despite the challenging fundraising environment, we are witnessing significant investments in AI-...
Despite the challenging fundraising environment, we are witnessing significant investments in AI-enabled drug discovery and development. Formation Bio's nearly $400M Series D and Xaira Therapeutics' emergence from stealth mode signal intensifying competition among major VC funds to lead in AI-powered biotech innovations.